Follow-up Study of the Immunogeneity and Safety of a Live Attenuated Tetravalent Dengue Vaccine TV005 among Taiwanese Adults 50 to 70 Years of Age: a Phase II Clinical Trial = 針對台灣50-70歲老年族群之4價登革疫苗TV005第二期臨床試驗後續追蹤分析研究

Project title

針對台灣50-70歲老年族群之4價登革疫苗TV005第二期臨床試驗後續追蹤分析研究

Internal ID

MOHW111-CDC-C-114-134110

Principal Investigator

Start Date

January 1, 2022

End Date

December 31, 2022

Investigators

SHAN-CHWEN CHANG

WANG-HUEI SHENG

Organizations

Internal Medicine-NTUH

Partner Organizations

Ministry of Health and Welfare